Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Kaplan Fox Alerts Investors of Unicycive Therapeutics, Inc. (UNCY) to a Securities Class Action Deadline on October 14, 2025
Via NewMediaWire
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Kaplan Fox Alerts Investors of Unicycive Therapeutics, Inc. (UNCY) to a Securities Class Action Deadline on October 14, 2025
Via TheNewswire.com
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Corporate Wins: Intel, Palo Alto Networks, and Novo Nordisk Drive Market Optimism
Via MarketMinute
Topics Artificial Intelligence Economy
Tickers INTC MDGL NVO PANW
Exposures Artificial Intelligence Economy Product Safety
Regeneron Says FDA Will Take More Time to Review Its Two Eylea HD Submissions
Via Stocktwits
Tickers REGN
Exposures Product Safety
Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity
Via Investor Brand Network
Tickers BMWYY NTRB
Exposures Product Safety
Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)
Via News Direct
Tickers MDCX
Exposures Product Safety
FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy
Via Benzinga
Tickers RCKT
Exposures Product Safety
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
September 15, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
September 15, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)
Via AB Newswire
Tickers MDCX
Exposures Product Safety
Ford CEO Jim Farley Says "There Are No Guarantees" With New $5 Billion EV Investment. Is Ford Stock a Risk Worth Taking for Investors?
Via The Motley Fool
Topics Electric Vehicles Government Product Recall
Tickers F GM TM
Exposures Electric Vehicles Legal Political
Shrimp Scare: Walmart Recalls Frozen Packs In 13 States After FDA Flags Radioactive Contaminants In Indonesian Supplier’s Shipping Containers
Via Stocktwits
Topics Product Recall Supply Chain
Tickers WMT
Exposures Legal Product Safety Supply Chain
Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns
Via MarketMinute
Tickers ALT LLY NVO PFE VKTX
Exposures Product Safety
Superintendent Andrew Jordan Urges Educators to Redefine Success
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Cloud Service Networks Highlights the Importance of Reliable VoIP for Dentist Offices
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Why Iovance Biotherapeutics Stock Was Climbing Today
Via The Motley Fool
Tickers IOVA
Exposures Product Safety
Cingulate Posts Wider Loss in Q2
Via The Motley Fool
Tickers CING
Exposures Product Safety
PTC Therapeutics Stock In The Spotlight After FDA Refuses Approval For Drug To Treat Neurodegenerative Disease, Analysts Are Divided
Via Stocktwits
Tickers EAOR IWMW PTCT
Exposures Product Safety
FDA Extends Decision Date On Regenxbio's Gene Therapy Into Next Year
Via Benzinga
Tickers RGNX
Exposures Product Safety
Fighting Against Fungal Resistance: BioVenic Takes Charge in Veterinary AMR Innovation
Via Get News
Exposures Product Safety
Why Novo Nordisk Stock Popped Today
Via The Motley Fool
Tickers LLY NVO VKTX
Exposures Product Safety
PTC Therapeutics Faces FDA Rejection On Rare Disease Treatment Over Efficacy Concerns
Via Benzinga
Tickers PTCT
Exposures Product Safety
Lantern Pharma Inc. (NASDAQ: LTRN) Releases Latest AI Breakthrough for Central Nervous System (‘CNS’) Drug Development with predictBBB.ai (TM): A High-Accuracy Open-Access AI Drug Development Tool
Via Investor Brand Network
Topics Artificial Intelligence
Tickers LTRN
Exposures Artificial Intelligence Product Safety
Investors Who Lost Money on Replimune Group, Inc. (REPL) Should Contact Levi & Korsinsky About Pending Class Action - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Investors Who Lost Money on Replimune Group, Inc. (REPL) Should Contact Levi &amp; Korsinsky About Pending Class Action - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.